基础医学与临床 ›› 2011, Vol. 31 ›› Issue (5): 529-533.

• 研究论文 • 上一篇    下一篇

糖原累积病Ⅰb型1例的临床和分子遗传分析

孙晓方1,陈适2,卢琳3,邱正庆4,肖新华5   

  1. 1. 中国医学科学院 北京协和医学院 北京协和医院
    2. 中国医学科学院 北京协和医学院 北京协和医院内分泌科
    3. 中国医学科学院北京协和医学院北京协和医院内分泌科
    4. 中国医学科学院北京协和医学院北京协和医院儿科
    5. 中国医学科学院 北京协和医学院 北京协和医院 内分泌科
  • 收稿日期:2011-01-13 修回日期:2011-03-09 出版日期:2011-05-05 发布日期:2011-05-06
  • 通讯作者: 肖新华 E-mail:xiaoxin-hua@medmail.com.cn
  • 基金资助:
    北京自然基金

Clinical and molecular genetic analysis for a patient with glycogen storage disease Ⅰb

SUN Xiao-fang 1,CHEN Shi 1,Lin LU,2,QIU Zheng-qing 3,Xin-hua XIAO,1   

  1. 1. PUMC Hospital, CAMS& PUMC
    2.
    3. PUMC Hospital, CAMS & PUMC
  • Received:2011-01-13 Revised:2011-03-09 Online:2011-05-05 Published:2011-05-06
  • Contact: Xin-hua XIAO, E-mail:xiaoxin-hua@medmail.com.cn

摘要: 目的 初步探讨1例糖原累积病Ⅰb型(GSDⅠb)患者的临床特点和致病基因,分析该疾病发生的分子遗传机制。方法 收集患者临床资料,抽提患者外周血白细胞基因组DNA,通过多聚酶链反应扩增葡萄糖-6-磷酸酶转位酶基因SLC37A4的9个外显子,用DNA直接测序法确定其突变位点。结果 患者临床表现及实验室检查完全符合GSDⅠb。经PCR测序发现SLC37A4基因第3外显子572位碱基C→T纯合突变(c.572 C>T),造成第191位的脯氨酸被亮氨酸替代(p. P191L),导致葡萄糖-6-磷酸转位酶活性下降。结论 SLC37A4基因突变导致的G6PT结构改变是该GSDⅠb患者临床表现的分子遗传基础。P191L纯合突变在中国大陆的报道尚属首次。相信不久,DNA突变分析将会成为糖原累积病Ⅰb型的主要确诊方法。

关键词: 糖原累积病Ⅰb型, 葡萄糖-6-磷酸酶转位酶, SLC37A4, 基因突变

Abstract: Objective To analyze the clinical and molecular genetic characteristics of a patient with glycogen storage disease Ⅰb (GSDⅠb). Methods Clinical profile and laboratory data were collected. Genomic DNA was extracted from leukocytes of peripheral blood of the patient. All nine exons and the exon-intron boundaries of the SLC37A4 gene were amplified by PCR. The mutations were identified by bidirectional sequencing of the PCR products. Results The patient was diagnosed as GSDⅠb according to the clinical presentations and laboratory examinations, SLC37A4 mutation was identified as a homozygous C>T transition at nucleotide position 527 of the cDNA. The missense mutation is located in exon 3, at codon 191, changing proline to leucine, which changes the conformation of the glucose-6-phosphate translocase (G6PT). Conclusion Through SLC37A4 gene mutation analysis, the clinical diagnosis of GSDⅠb was confirmed. The alternation of G6PT structure caused by SLC37A4 gene mutation is the molecular genetic mechanism to explain clinical manifestation of the patient. To our knowledge, this is the first report of P191L as a cause of GSD1b in Han China mainland. In the future, GSDⅠb could be diagnosed through genomic DNA mutation analysis.

Key words: glycogen storage disease Ⅰb, glucose-6-phosphate translocase, SLC37A4, mutation